Consultations

Treating patients with advanced Kaposi sarcoma often requires a team approach, as follows:

Medical oncologists often administer systemic chemotherapy.
Radiation oncologists tend to favor radiotherapy options.
Infectious diseases/HIV specialists may be needed for HIV and opportunistic infections.

Prevention

Reducing the HHV-8 infection rate prevents Kaposi sarcoma development.

Suggestions have been made that some antiherpetic agents, particularly foscarnet, may lower the HHV-8 infection rate.

Screening transplant recipients for HHV-8 infection may be beneficial.^{[74, 75, 76, 77, 78]}Testing donors and recipients for HHV-8 is difficult, as there are no validated commercial serology kits available; however, limited HHV-8 antibody testing is available through some US reference laboratories and the US Centers for Disease Control and Prevention.^[79]Many US donors originate from groups at high risk of HHV-8 transmission to recipients.

Use of the highly active anti-HIV therapy (ie, HAART) appears to significantly reduce the risk of developing new Kaposi sarcoma.^[35]

Long-Term Monitoring

Careful follow-up monitoring is essential for patients with Kaposi sarcoma (KS).

Medication

Friedman-Kien AE. Disseminated Kaposi's sarcoma syndrome in young homosexual men. J Am Acad Dermatol. 1981 Oct. 5(4):468-71. [QxMD MEDLINE Link].
Gottlieb MS, Schroff R, Schanker HM, Weisman JD, Fan PT, Wolf RA, et al. Pneumocystis carinii pneumonia and mucosal candidiasis in previously healthy homosexual men: evidence of a new acquired cellular immunodeficiency. N Engl J Med. 1981 Dec 10. 305(24):1425-31. [QxMD MEDLINE Link].
Allan AE, Shoji T, Li N, Burlage A, Davis B, Bhawan J. Two cases of Kaposi's sarcoma mimicking Stewart-Treves syndrome found to be human herpesvirus-8 positive. Am J Dermatopathol. 2001 Oct. 23(5):431-6. [QxMD MEDLINE Link].
Schwartz RA, Micali G, Nasca MR, Scuderi L. Kaposi sarcoma: a continuing conundrum. J Am Acad Dermatol. 2008 Aug. 59(2):179-206; quiz 207-8. [QxMD MEDLINE Link].
Ruocco V, Ruocco E, Schwartz RA, Janniger CK. Kaposi sarcoma and quinine: A potentially overlooked triggering factor in millions of Africans. J Am Acad Dermatol. 2011 Feb. 64(2):434-6. [QxMD MEDLINE Link].
Brambilla L, Bellinvia M, Tourlaki A, Scoppio B, Gaiani F, Boneschi V. Intralesional vincristine as first-line therapy for nodular lesions in classic Kaposi sarcoma: a prospective study in 151 patients. Br J Dermatol. 2009 Nov 25. [QxMD MEDLINE Link].
Fardet L, Stoebner PE, Bachelez H, et al. Treatment with taxanes of refractory or life-threatening Kaposi sarcoma not associated with human immunodeficiency virus infection. Cancer. 2006 Apr 15. 106(8):1785-9. [QxMD MEDLINE Link].
Di Lorenzo G, Di Trolio R, Montesarchio V, et al. Pegylated liposomal doxorubicin as second-line therapy in the treatment of patients with advanced classic Kaposi sarcoma: a retrospective study. Cancer. 2008 Mar 1. 112(5):1147-52. [QxMD MEDLINE Link].
Abdelmaksoud A, Filoni A, Giudice G, Vestita M. Classic and HIV-related Kaposi sarcoma treated with 0.1% topical timolol gel. J Am Acad Dermatol. 2017 Jan. 76 (1):153-155. [QxMD MEDLINE Link].
Özdemir M, Balevi A. Successful Treatment of Classic Kaposi Sarcoma With Long-Pulse Neodymium-Doped Yttrium Aluminum Garnet (Nd: YAG) Laser: A Preliminary Study. Dermatol Surg. 2017 Feb 1. [QxMD MEDLINE Link].
Ronchese F. Kaposi's sarcoma; an overlooked essay of 1882. AMA Arch Derm. 1958 May. 77(5):542-5. [QxMD MEDLINE Link].
Schiavo AL, Ruocco V, Marino F, Ferraiolo S, Pinto F, Orlando G. Tommaso de Amicis, Augusto Ducrey, Lodovico Tommasi: three Neapolitan stars in the dermatovenereology firmament. Int J Dermatol. 1996 Jan. 35(1):57-62. [QxMD MEDLINE Link].
Borkovic SP, Schwartz RA. Kaposi's sarcoma presenting in the homosexual man -- a new and striking phenomenon!. Ariz Med. 1981 Dec. 38(12):902-4. [QxMD MEDLINE Link].
Borkovic SP, Schwartz RA. Kaposi's sarcoma. Am Fam Physician. 1982 Oct. 26(4):133-7. [QxMD MEDLINE Link].
Ruocco V, Ruocco E, Schwartz RA, Janniger CK. Kaposi’s sarcoma and quinine: a potentially overlooked triggering factor in millions of Africans. J Am Acad Dermatol. 2010. in press:
Biggar RJ, Whitby D, Marshall V, Linhares AC, Black F. Human herpesvirus 8 in Brazilian Amerindians: a hyperendemic population with a new subtype. J Infect Dis. 2000 May. 181(5):1562-8. [QxMD MEDLINE Link].
Ascoli V, Zambon P, Manno D, et al. Variability in the incidence of classic Kaposi's sarcoma in the Veneto region, Northern Italy. Tumori. 2003 Mar-Apr. 89(2):122-4. [QxMD MEDLINE Link].
Santarelli R, De Marco R, Masala MV, et al. Direct correlation between human herpesvirus-8 seroprevalence and classic Kaposi's sarcoma incidence in Northern Sardinia. J Med Virol. 2001 Oct. 65(2):368-72. [QxMD MEDLINE Link].
Moore PS, Chang Y. Kaposi's sarcoma-associated herpesvirus immunoevasion and tumorigenesis: two sides of the same coin?. Annu Rev Microbiol. 2003. 57:609-39. [QxMD MEDLINE Link].
Tornesello ML, Biryahwaho B, Downing R, et al. Human herpesvirus type 8 variants circulating in Europe, Africa and North America in classic, endemic and epidemic Kaposi's sarcoma lesions during pre-AIDS and AIDS era. Virology. 2010 Mar 15. 398(2):280-9. [QxMD MEDLINE Link].
Serwin AB, Mysliwiec H, Wilder N, Schwartz RA, Chodynicka B. Three cases of classic Kaposi's sarcoma with different subtypes of Kaposi's sarcoma-associated herpesvirus. Int J Dermatol. 2006 Jul. 45(7):843-6. [QxMD MEDLINE Link].
Cassar O, Blondot ML, Mohanna S, et al. Human herpesvirus 8 genotype E in patients with Kaposi sarcoma, Peru. Emerg Infect Dis. 2010 Sep. 16(9):1459-62. [QxMD MEDLINE Link].
Ramos da Silva S, Ferraz da Silva AP, Bacchi MM, Bacchi CE, Elgui de Oliveira D. KSHV genotypes A and C are more frequent in Kaposi sarcoma lesions from Brazilian patients with and without HIV infection, respectively. Cancer Lett. 2011 Feb 1. 301(1):85-94. [QxMD MEDLINE Link].
Dupin N, Grange PA. Looking for the target cell of Kaposi's sarcoma-associated herpesvirus. J Invest Dermatol. 2006 Mar. 126(3):545-7. [QxMD MEDLINE Link].
Elliott AM, Luzze H, Quigley MA, et al. A randomized, double-blind, placebo-controlled trial of the use of prednisolone as an adjunct to treatment in HIV-1-associated pleural tuberculosis. J Infect Dis. 2004 Sep 1. 190(5):869-78. [QxMD MEDLINE Link].
Hwang A, Iskandar AS, Kerr WT, Farrell S, Plaxe SC, Dasanu CA. Clinico-epidemiologic characteristics and patterns of care in Kaposi's sarcoma: Data from a single-institution series. J Oncol Pharm Pract. 2019 Apr 2. 1078155219838614. [QxMD MEDLINE Link].
Gantt S, Kakuru A, Wald A, et al. Clinical presentation and outcome of epidemic Kaposi sarcoma in Ugandan children. Pediatr Blood Cancer. 2010 May. 54(5):670-4. [QxMD MEDLINE Link]. [Full Text].
Onunu AN, Okoduwa C, Eze EU, Adeyekun AA, Kubeyinje EP, Schwartz RA. Kaposi's sarcoma in Nigeria. Int J Dermatol. 2007 Mar. 46(3):264-7. [QxMD MEDLINE Link].
Polesel J, Franceschi S, Suligoi B, Crocetti E, Falcini F, Guzzinati S, et al. Cancer incidence in people with AIDS in Italy. Int J Cancer. 2010 Jan 4. [QxMD MEDLINE Link].
Stratigos JD, Potouridou I, Katoulis AC, et al. Classic Kaposi's sarcoma in Greece: a clinico-epidemiological profile. Int J Dermatol. 1997 Oct. 36(10):735-40. [QxMD MEDLINE Link].
Barco D, Alegre M, Alomar A. [Classic kaposi sarcoma associated with lymphedema following arterial catheterization]. Actas Dermosifiliogr. 2008 Oct. 99(8):665-7. [QxMD MEDLINE Link].
Ruocco V, Schwartz RA, Ruocco E. Lymphedema: an immunologically vulnerable site for development of neoplasms. J Am Acad Dermatol. 2002 Jul. 47(1):124-7. [QxMD MEDLINE Link].
Atzori L, Fadda D, Ferreli C, et al. Classic Kaposi's sarcoma in southern Sardinia, Italy. Br J Cancer. 2004 Oct 4. 91(7):1261-2. [QxMD MEDLINE Link].
Kaasinen E, Aavikko M, Vahteristo P, Patama T, Li Y, Saarinen S, et al. Nationwide registry-based analysis of cancer clustering detects strong familial occurrence of kaposi sarcoma. PLoS One. 2013. 8(1):e55209. [QxMD MEDLINE Link].
Castilho JL, Kim A, Jenkins CA, et al. Antiretroviral therapy and Kaposi's sarcoma trends and outcomes among adults with HIV in Latin America. J Int AIDS Soc. 2021 Jan. 24 (1):e25658. [QxMD MEDLINE Link].
Qunibi W, Al-Furayh O, Almeshari K, et al. Serologic association of human herpesvirus eight with posttransplant Kaposi's sarcoma in Saudi Arabia. Transplantation. 1998 Feb 27. 65(4):583-5. [QxMD MEDLINE Link].
Phipps W, Ssewankambo F, Nguyen H, et al. Gender differences in clinical presentation and outcomes of epidemic Kaposi sarcoma in Uganda. PLoS One. 2010 Nov 12. 5(11):e13936. [QxMD MEDLINE Link]. [Full Text].
Pitche PT, Kombate K, Owono F, Tchangai-Walla K. Kaposi's sarcoma in a hospital setting in Lome (Togo): a study of 93 cases. Int J Dermatol. 2007 Oct. 46 Suppl 1:42-4. [QxMD MEDLINE Link].
Stefan DC, Stones DK, Wainwright L, Newton R. Kaposi sarcoma in South African children. Pediatr Blood Cancer. 2011 Mar. 56(3):392-6. [QxMD MEDLINE Link].
Achenbach CJ, Harrington RD, Dhanireddy S, Crane HM, Casper C, Kitahata MM. Paradoxical Immune Reconstitution Inflammatory Syndrome in HIV-Infected Patients Treated With Combination Antiretroviral Therapy After AIDS-Defining Opportunistic Infection. Clin Infect Dis. 2012 Feb. 54(3):424-33. [QxMD MEDLINE Link]. [Full Text].
Stover KR, Molitorisz S, Swiatlo E, Muzny CA. A Fatal Case of Kaposi Sarcoma Due to Immune Reconstitution Inflammatory Syndrome. Am J Med Sci. 2012 Jan 6. [QxMD MEDLINE Link].
Wolf R, Brenner S, Ruocco V, Filioli FG. Isotopic response. Int J Dermatol. 1995 May. 34(5):341-8. [QxMD MEDLINE Link].
Micali G, Nasca MR, De Pasquale R, Innocenzi D. Primary classic Kaposi's sarcoma of the penis: report of a case and review. J Eur Acad Dermatol Venereol. 2003 May. 17(3):320-3. [QxMD MEDLINE Link].
Schwartz RA, Cohen JB, Watson RA, et al. Penile Kaposi's sarcoma preceded by chronic penile lymphoedema. Br J Dermatol. 2000 Jan. 142(1):153-6. [QxMD MEDLINE Link].
Farshidpour M, Marjani M, Baghaei P, Tabarsi P, Masjedi H, Asadi Kani ZF, et al. Disseminated Kaposi's Sarcoma with the Involvement of Penis in the Setting of HIV Infection. Indian J Dermatol. 2015 Jan-Feb. 60(1):104. [QxMD MEDLINE Link]. [Full Text].
Elsaie ML, Shehu YM, Sani MU, Borodo MM, Mohammed AZ. Disseminated vitiligo developing around Kaposi sarcoma nodules in an AIDS patient. Cutis. 2011 Nov. 88(5):237-9. [QxMD MEDLINE Link].
Shah AS, Abu Saleh OM. Kaposi Sarcoma Masquerading as a Tooth Abscess in a Patient With Human Immunodeficiency Virus. Mayo Clin Proc. 2019 Feb. 94 (2):370. [QxMD MEDLINE Link].
Satta R, Biondi G, Cottoni F. Rainbow pattern: practical applications of dermoscopy in Kaposi's sarcoma. G Ital Dermatol Venereol. 2016 Apr. 107 (2):206-7. [QxMD MEDLINE Link].
McClain CM, Haws AL, Galfione SK, Rapini RP, Hafeez Diwan A. Pyogenic Granuloma-Like Kaposi's Sarcoma. J Cutan Pathol. 2016 Jun. 43 (6):549-51. [QxMD MEDLINE Link].
Korekawa A, Kaneko T, Nakano H, Sawamura D. Pyogenic granuloma-like Kaposi's sarcoma on the first toe. J Dermatol. 2018 Feb 14. [QxMD MEDLINE Link].
Megaly M, Boshra N. Pyogenic granuloma-like Kaposi's sarcoma. Lancet. 2022 Apr 23. 399 (10335):e38. [QxMD MEDLINE Link].
Aïm F, Rosier L, Dumontier C. Isolated Kaposi sarcoma of the finger pulp in an AIDS patient. Orthop Traumatol Surg Res. 2012 Feb. 98(1):126-8. [QxMD MEDLINE Link].
Schuch LF, Kovalski LNS, Leite AA, et al. Oral lymphangioma-like Kaposi sarcoma: a Brazilian case report in a scenario of a still high number of HIV infections. Oral Maxillofac Surg. 2022 Mar. 26 (1):171-176. [QxMD MEDLINE Link].
Silapunt S, Jordon RE, Piao Y, Tsai KY. Kaposi sarcoma presenting as a cutaneous horn. J Am Acad Dermatol. 2011 Feb. 64(2):447-8. [QxMD MEDLINE Link].
Manzardo C, Guardo AC, Letang E, Plana M, Gatell JM, Miro JM. Opportunistic infections and immune reconstitution inflammatory syndrome in HIV-1-infected adults in the combined antiretroviral therapy era: a comprehensive review. Expert Rev Anti Infect Ther. 2015 Apr 10. 1-17. [QxMD MEDLINE Link].
Vanousova D, Jilich D, Machala L, et al. [Diagnostic pitfalls of HIV-associated Kaposi's sarcoma]. Klin Onkol. 2010. 23(5):285-92. [QxMD MEDLINE Link].
Straka L, Adamicová K. [Reactive angioendotheliomatosis--a rare disease mimicking Kaposi sarcoma: a case report]. Cesk Patol. 2004 Oct. 40(4):162-6. [QxMD MEDLINE Link].
Croteau SE, Kozakewich HP, Perez-Atayde AR, Fishman SJ, Alomari AI, Chaudry G, et al. Kaposiform lymphangiomatosis: a distinct aggressive lymphatic anomaly. J Pediatr. 2014 Feb. 164(2):383-8. [QxMD MEDLINE Link]. [Full Text].
Mansur AT, Demirci GT, Ozbal Koc EA, Yildiz S. An unusual lesion on the nose: microvenular hemangioma. Dermatol Pract Concept. 2018 Jan. 8 (1):7-11. [QxMD MEDLINE Link].
Yaqub S, Stepenaskie SA, Farshami FJ, Sibbitt WL Jr, Fangtham M, Emil NS, et al. Kaposi Sarcoma as a Cutaneous Vasculitis Mimic: Diagnosis and Treatment. J Clin Aesthet Dermatol. 2019 Nov. 12 (11):23-26. [QxMD MEDLINE Link].
Pinos León VH, Granizo Rubio JD. Acral pseudolymphomatous angiokeratoma of children with rainbow pattern: A mimicker of Kaposi sarcoma. J Am Acad Dermatol. 2017 Feb. 76 (2S1):S25-S27. [QxMD MEDLINE Link].
Patel RM, Goldblum JR, Hsi ED. Immunohistochemical detection of human herpes virus-8 latent nuclear antigen-1 is useful in the diagnosis of Kaposi sarcoma. Mod Pathol. 2004 Apr. 17(4):456-60. [QxMD MEDLINE Link].
O'Mahony D, Gandjbakche A, Hassan M, Vogel A, Yarchoan R. Imaging techniques for Kaposi's sarcoma. J HIV Ther. 2008 Sep. 13(3):65-71. [QxMD MEDLINE Link].
Theron S, Andronikou S, Du Plessis J, et al. Pulmonary Kaposi sarcoma in six children. Pediatr Radiol. 2007 Dec. 37(12):1224-9. [QxMD MEDLINE Link].
Luzar B, Antony F, Ramdial PK, Calonje E. Intravascular Kaposi's sarcoma - a hitherto unrecognized phenomenon. J Cutan Pathol. 2007 Nov. 34(11):861-4. [QxMD MEDLINE Link].
O'donnell PJ, Pantanowitz L, Grayson W. Unique Histologic Variants of Cutaneous Kaposi Sarcoma. Am J Dermatopathol. 2010 Jan 14. [QxMD MEDLINE Link].
Yang SH, Leboit PE. Angiomatous kaposi sarcoma: a variant that mimics hemangiomas. Am J Dermatopathol. 2014 Mar. 36(3):229-37. [QxMD MEDLINE Link].
Wada DA, Perkins SL, Tripp S, Coffin CM, Florell SR. Human herpesvirus 8 and iron staining are useful in differentiating Kaposi sarcoma from interstitial granuloma annulare. Am J Clin Pathol. 2007 Feb. 127(2):263-70. [QxMD MEDLINE Link].
Bunn BK, Carvalho Mde V, Louw M, Vargas PA, van Heerden WF. Microscopic diversity in oral Kaposi sarcoma. Oral Surg Oral Med Oral Pathol Oral Radiol. 2013 Feb. 115(2):241-8. [QxMD MEDLINE Link].
Speicher DJ, Wanzala P, D'Lima M, Njiru A, Chindia M, Dimba E, et al. Diagnostic challenges of oral and cutaneous Kaposi's sarcoma in resource-constrained settings. J Oral Pathol Med. 2015 Mar 17. [QxMD MEDLINE Link].
Brambilla L, Boneschi V, Taglioni M, Ferrucci S. Staging of classic Kaposi's sarcoma: a useful tool for therapeutic choices. Eur J Dermatol. 2003 Jan-Feb. 13(1):83-6. [QxMD MEDLINE Link].
Krown SE, Metroka C, Wernz JC. Kaposi's sarcoma in the acquired immune deficiency syndrome: a proposal for uniform evaluation, response, and staging criteria. AIDS Clinical Trials Group Oncology Committee. J Clin Oncol. 1989 Sep. 7(9):1201-7. [QxMD MEDLINE Link].
Mitsuyasu RT. Clinical variants and staging of Kaposi's sarcoma. Semin Oncol. 1987 Jun. 14(2 Suppl 3):13-8. [QxMD MEDLINE Link].
Cattani P, Capuano M, Graffeo R, et al. Kaposi's sarcoma associated with previous human herpesvirus 8 infection in kidney transplant recipients. J Clin Microbiol. 2001 Feb. 39(2):506-8. [QxMD MEDLINE Link].
Frances C, Mouquet C, Marcelin AG, et al. Outcome of kidney transplant recipients with previous human herpesvirus-8 infection. Transplantation. 2000 May 15. 69(9):1776-9. [QxMD MEDLINE Link].
Khan MY, Khanam H, Koneru B, Schwartz RA. Kaposi's sarcoma in a liver transplant series. J Med. 1999. 30(3-4):185-90. [QxMD MEDLINE Link].
Khan MY, Khanman H, Koneru B. Kaposi's sarcoma in a liver transplantation series. J Med. 2000. 30:185-90.
Sabeel AI, Qunibi WY, Alfurayh OA, Al-Meshari K. Kaposi's sarcoma in Sudanese renal transplant recipients: a report from a single center. J Nephrol. 2003 May-Jun. 16(3):412-6. [QxMD MEDLINE Link].
Dollard SC, Annambhotla P, Wong P, Meneses K, Amin MM, La Hoz RM, et al. Donor-derived human herpesvirus 8 and development of Kaposi sarcoma among 6 recipients of organs from donors with high-risk sexual and substance use behavior. Am J Transplant. 2021 Feb. 21 (2):681-688. [QxMD MEDLINE Link].
Klein E, Schwartz RA, Laor Y, Milgrom H, Burgess GH, Holtermann OA. Treatment of Kaposi's sarcoma with vinblastine. Cancer. 1980 Feb. 45(3):427-31. [QxMD MEDLINE Link].
Goiriz R, Rios-Buceta L, De Arriba AG, Aragues M, Garcia-Diez A. Treatment of classic Kaposi's sarcoma with topical imiquimod. Dermatol Surg. 2009 Jan. 35(1):147-9. [QxMD MEDLINE Link].
Prinz Vavricka BM, Hofbauer GF, Dummer R, French LE, Kempf W. Topical treatment of cutaneous Kaposi sarcoma with imiquimod 5% in renal-transplant recipients: a clinicopathological observation. Clin Exp Dermatol. 2012 Feb 2. [QxMD MEDLINE Link].
Koon HB, Fingleton B, Lee JY, et al. Phase II AIDS Malignancy Consortium trial of topical halofuginone in AIDS-related Kaposi sarcoma. J Acquir Immune Defic Syndr. 2011 Jan 1. 56(1):64-8. [QxMD MEDLINE Link]. [Full Text].
Reschke R, Grunewald S, Schüürmann M, Simon JC, Ziemer M. Value of first-line surgical treatment for classic Kaposi sarcoma and potential use of checkpoint inhibitors. J Dtsch Dermatol Ges. 2020 Mar. 18 (3):256-262. [QxMD MEDLINE Link].
Rubegni P, Sbano P, De Aloe G, Flori ML, Fimiani M. Thalidomide in the treatment of Kaposi's sarcoma. Dermatology. 2007. 215(3):240-4. [QxMD MEDLINE Link].
Paghdal KV, Schwartz RA. Sirolimus (rapamycin): from the soil of Easter Island to a bright future. J Am Acad Dermatol. 2007 Dec. 57(6):1046-50. [QxMD MEDLINE Link].
Boratynska M, Watorek E, Smolska D, Patrzalek D, Klinger M. Anticancer effect of sirolimus in renal allograft recipients with de novo malignancies. Transplant Proc. 2007 Nov. 39(9):2736-9. [QxMD MEDLINE Link].
Detroyer D, Deraedt K, Schöffski P, Hauben E, Lagrou K, Naesens M, et al. Resolution of diffuse skin and systemic Kaposi's sarcoma in a renal transplant recipient after introduction of everolimus: a case report. Transpl Infect Dis. 2015 Apr. 17(2):303-7. [QxMD MEDLINE Link].
Leder HA, Galor A, Peters GB, Kedhar SR, Dunn JP, Thorne JE. Resolution of conjunctival Kaposi sarcoma after institution of highly active antiretroviral therapy alone. Br J Ophthalmol. 2008 Jan. 92(1):151. [QxMD MEDLINE Link].
Olweny CL, Borok M, Gudza I, et al. Treatment of AIDS-associated Kaposi's sarcoma in Zimbabwe: results of a randomized quality of life focused clinical trial. Int J Cancer. 2005 Feb 10. 113(4):632-9. [QxMD MEDLINE Link].
Cianfrocca M, Lee S, Von Roenn J, et al. Randomized trial of paclitaxel versus pegylated liposomal doxorubicin for advanced human immunodeficiency virus-associated Kaposi sarcoma: evidence of symptom palliation from chemotherapy. Cancer. 2010 Aug 15. 116(16):3969-77. [QxMD MEDLINE Link].
Molyneux E, Davidson A, Orem J, Hesseling P, Balagadde-Kambugu J, Githanga J, et al. The management of children with Kaposi sarcoma in resource limited settings. Pediatr Blood Cancer. 2012 Dec 19. [QxMD MEDLINE Link].
Delyon J, Biard L, Renaud M, et al. PD-1 blockade with pembrolizumab in classic or endemic Kaposi's sarcoma: a multicentre, single-arm, phase 2 study. Lancet Oncol. 2022 Apr. 23 (4):491-500. [QxMD MEDLINE Link].

Media Gallery

Elderly American man of Armenian origin with characteristic violaceous plaques of the legs, a good example of classic Kaposi sarcoma.
Man who is homosexual and has HIV infection and Kaposi sarcoma.
Man who is homosexual and has HIV infection and Kaposi sarcoma.
Man who is homosexual and has HIV infection and Kaposi sarcoma.
Elderly man of Mediterranean lineage with hyperkeratotic nodule of Kaposi sarcoma on sole of foot.
Man who is homosexual and has HIV infection and Kaposi sarcoma.
Man who is homosexual and has HIV infection and Kaposi sarcoma.
Man who is homosexual and has HIV infection and Kaposi sarcoma.
A 35-year-old man with dome-shaped locally aggressive tumors, an example of exophytic Kaposi sarcoma with cavernous hemangiomalike histology.
Ecchymotic Kaposi sarcoma in a man who is homosexual.
Intermediate lesion showing moderately enlarged spindle cells, some of which line poorly formed blood vessels that open into the interstitium with extravasation of erythrocytes. Erythrophagocytosis by these spindle cells is noted in places (hematoxylin and eosin, magnification X80).
Early lesion showing increased cellularity of the dermis with slightly enlarged spindle cells of focally fine stellate blood vessels that open at their corners into the interstitium (hematoxylin and eosin, magnification X40).
Keloidal Kaposi sarcoma demonstrating features both of keloids and Kaposi sarcoma (hematoxylin and eosin, magnification X80).
Oral Kaposi sarcoma.
Kaposi sarcoma of the leg.
Late lesion showing masses of moderately atypical spindle cells in a haphazard array, some of which line poorly formed blood vessels. Many of the spindle cells show erythrophagocytosis (hematoxylin and eosin, magnification X40).
Late lesion showing atypical spindle cells, some of which are lining poorly formed blood vessels, with prominent erythrophagocytosis by the cells (hematoxylin and eosin, magnification X80).

of 17

Author

Robert A Schwartz, MD, MPH Professor and Head of Dermatology, Professor of Pathology, Professor of Pediatrics, Professor of Medicine, Rutgers New Jersey Medical School

Robert A Schwartz, MD, MPH is a member of the following medical societies: Alpha Omega Alpha, American Academy of Dermatology, New York Academy of Medicine, Royal College of Physicians of Edinburgh, Sigma Xi, The Scientific Research Honor Society

Disclosure: Nothing to disclose.

Coauthor(s)

W Clark Lambert, MD, PhD Clinical Professor of Pathology, Clinical Professor of Medicine (Professor of Dermatology), Rutgers New Jersey Medical School; Professor of Pathology, Rutgers Graduate School of Biomedical Sciences

W Clark Lambert, MD, PhD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Dermatology, American College of Physicians, American Dermatological Association, American Federation for Clinical Research, American Society of Dermatopathology, College of American Pathologists, Dermatological Society of New Jersey, Institute of Electrical and Electronics Engineers, International Academy of Pathology, International Federation of Pigment Cell Societies, International Society of Dermatopathology, Medical Society of New Jersey, Sigma Xi, The Scientific Research Honor Society, Society for Investigative Dermatology, Xeroderma Pigmentosum Society

Disclosure: Nothing to disclose.

Specialty Editor Board

Michael J Wells, MD, FAAD Dermatologic/Mohs Surgeon, The Surgery Center at Plano Dermatology

Michael J Wells, MD, FAAD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Dermatology, American Medical Association, Texas Medical Association

Disclosure: Nothing to disclose.

Christen M Mowad, MD Professor, Department of Dermatology, Geisinger Medical Center

Christen M Mowad, MD is a member of the following medical societies: Alpha Omega Alpha, Noah Worcester Dermatological Society, Pennsylvania Academy of Dermatology, American Academy of Dermatology, Phi Beta Kappa

Disclosure: Nothing to disclose.

Chief Editor

Dirk M Elston, MD Professor and Chairman, Department of Dermatology and Dermatologic Surgery, Medical University of South Carolina College of Medicine

Dirk M Elston, MD is a member of the following medical societies: American Academy of Dermatology

Disclosure: Nothing to disclose.

Additional Contributors

Abby S Van Voorhees, MD Assistant Professor, Director of Psoriasis Services and Phototherapy Units, Department of Dermatology, University of Pennsylvania School of Medicine, Hospital of the University of Pennsylvania

Abby S Van Voorhees, MD is a member of the following medical societies: American Academy of Dermatology, Women's Dermatologic Society, National Psoriasis Foundation, American Medical Association, Phi Beta Kappa, Sigma Xi, The Scientific Research Honor Society

Disclosure: Received honoraria from Amgen for consulting; Received honoraria from Abbott for consulting; Partner received salary from Merck for management position; Received honoraria from Abbott for speaking and teaching; Received honoraria from Amgen for review panel membership; Received honoraria from Centocor for consulting; Received honoraria from Leo for consulting; Received none from Merck for other.

Sections Dermatologic Manifestations of Kaposi Sarcoma
Overview
Presentation
DDx
Workup
Treatment
Medication
Questions & Answers
Media Gallery
References

Dermatologic Manifestations of Kaposi Sarcoma Treatment & Management

Consultations

Prevention

Long-Term Monitoring

References

Tables

Contributor Information and Disclosures

What would you like to print?